Recently, ShanghaiRanking, a higher‑education evaluation institution, officially released the 2026 ShanghaiRanking’s Global Ranking of Academic Subjects (GRAS). Eight disciplines ofSDFMU have made it to the ranking list, namely Biomedical Engineering, Pharmacy, Nursing, Basic Medicine, Medical Technology, Materials Science and Engineering, Nanoscience and Technology, and Instrument Science. The number of listed disciplines has increased by three compared with 2025, representing a 60% growth rate. This marks new progress in our disciplinary strength and global academic influence.
In this round of rankings, SDFMU has achieved coordinated progress across Medicine, Life Sciences and Engineering. Biomedical Engineering and Pharmacy delivered standout performances and entered the global Top 200. Biomedical Engineering ranks 123rd worldwide, jumping 61 places from last year; Pharmacy sits at 175th globally, an advance of 57 places year‑on‑year. In addition, Basic Medicine, Medical Technology, and Nanoscience and Technology have all climbed in rankings, demonstrating robust momentum for development. Three disciplines-Nursing, Materials Science and Engineering, and Instrument Science-appear on this ranking for the first time, emerging as new growth drivers for our disciplinary development.
In recent years, centering on the goal of building “Double First‑Class” institutions, SDFMU has followed the laws of disciplinary development, pursued sustained, intensive efforts and adhered to connotation‑driven high‑quality development. It has continuously improved the disciplinary innovation system featuring medicine‑engineering and medicine‑science integration to foster new impetus for disciplinary advancement. The remarkable results of multiple disciplines in this authoritative global ranking fully demonstrate our achievements in strategic disciplinary layout, research‑driven innovation, and development of high‑caliber faculty teams.
Moving forward, fulfilling its mission under the Healthy China Initiative, SDFMU will focus on key areas including major chronic disease prevention and treatment, high‑end medical equipment R&D, and innovation in intelligent medical technologies. It will consolidate solid foundations and gather momentum toward building a domestically leading application‑oriented research‑oriented first‑class university with prominent international influence.
